Abstract 1979: Dissecting the cellular and molecular players of T Cell Bispecific (TCB) antibody-mediated CRS

作者
Gabrielle Leclercq-Cohen,Nathalie Steinhoff,Llucia Albertí Servera,Emilio Yángüez,Sina Nassiri,Anna Maria Giusti,Anneliese Schneider,Christian Klein,Hélène Haegel,Pablo Umaña,Johannes Sam,Marina Bacac
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:82 (12_Supplement): 1979-1979
标识
DOI:10.1158/1538-7445.am2022-1979
摘要

Abstract T-cell bispecific antibodies (TCBs) are a promising class of immunotherapies that activate T cells by engaging the CD3ε chain of the T-cell receptor and simultaneously binding to the tumor-associated antigens on target cells. They enable the formation of a cytotoxic synapse where the release of perforin and granzyme B induces target cell killing. Nevertheless, on-target activation of T-cells is associated with an intrinsic risk of cytokine release syndrome (CRS), one of the safety risks associated with the treatment with T cell engaging therapies. In this work, we focused on dissecting the cellular and molecular players of TCB-mediated cytokine release using single cell RNA sequencing of whole blood treated with CD20-TCB, targeting CD20-expressing B cells, as model system. In particular, we aimed at dissecting the kinetics of events along with identifying the main players that “trigger” with others that “amplify” the cytokine release. In accordance with previous reports, we show that activated T-cells initiate the cytokine cascade by releasing cytokines and chemokines stimulating monocytes and neutrophils that consequently amplify TCB-induced cytokine release. Additionally, we revealed inflammatory gene signatures and pathways evolving over treatment time in T cells, monocytes and neutrophils, highlighting potential novel biomarkers of CRS. Furthermore, using an in vitro co-culture of peripheral blood mononuclear cells (PBMCs) with tumor cells or a whole blood assay in the presence of CD20-TCB and neutralizing antibodies against the identified molecular targets, we confirmed their role in triggering or amplifying cytokine release. We further corroborated their role by depleting and/or blocking different cellular and molecular players in tumor-bearing humanized NSG mice treated with CD20-TCB. Last, we assessed the effects of dexamethasone, adalimumab (anti-TNF-a), tocilizumab (anti-IL-6R) and anakinra (anti-IL-1R) on cytokine release and anti-tumor efficacy of CD20-TCB in the same in vivo tumor model. Among the considered mitigation strategies, dexamethasone and adalimumab reduced the level of cytokines and chemokines, correlating with milder CRS signs upon TCB treatment. Importantly, none of the mitigations strategies interfered with anti-tumor efficacy, except adalimumab, which partially impacted the tumor growth inhibition and affected early T cell infiltration in the tumor.In summary, our findings reveal novel molecular and cellular biomarkers of TCB-induced cytokine release, and in addition provide insights on the potential mitigation strategies of the same. Our work sheds new light on the kinetics of mechanisms of inflammation driven by TCBs. Citation Format: Gabrielle Leclercq, Nathalie Steinhoff, LLucia Alberti-Serverra, Emilio Yángüez, Sina Nassiri, Anna-Maria Giusti, Anneliese Schneider, Christian Klein, Hélène Haegel, Pablo Umaña, Johannes Sam, Marina Bacac. Dissecting the cellular and molecular players of T Cell Bispecific (TCB) antibody-mediated CRS [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 1979.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
危机的天佑完成签到,获得积分20
刚刚
刚刚
1秒前
今后的应助被北音采纳,获得10
1秒前
姜昊彤完成签到,获得积分10
2秒前
2秒前
邓111111发布了新的文献求助10
3秒前
3秒前
3秒前
星辰大海的应助被科研通管家采纳,获得10
4秒前
赘婿的应助被科研通管家采纳,获得10
4秒前
无花果的应助被科研通管家采纳,获得10
4秒前
汉堡包的应助被科研通管家采纳,获得10
4秒前
田様的应助被科研通管家采纳,获得10
4秒前
嘻嘻哈哈的应助被科研通管家采纳,获得10
4秒前
Ava的应助被科研通管家采纳,获得10
4秒前
科研通AI6.3的应助被nnam采纳,获得10
4秒前
英俊的铭的应助被科研通管家采纳,获得10
4秒前
烟花的应助被科研通管家采纳,获得10
5秒前
FashionBoy的应助被科研通管家采纳,获得10
5秒前
青栀的应助被科研通管家采纳,获得10
5秒前
5秒前
Ava的应助被科研通管家采纳,获得10
5秒前
5秒前
5秒前
5秒前
慕青的应助被科研通管家采纳,获得10
5秒前
天天向上的应助被科研通管家采纳,获得10
5秒前
无极微光的应助被科研通管家采纳,获得20
5秒前
M7完成签到,获得积分10
6秒前
充电宝的应助被科研通管家采纳,获得10
6秒前
滴滴答答完成签到,获得积分10
6秒前
无花果的应助被科研通管家采纳,获得10
6秒前
脑洞疼的应助被科研通管家采纳,获得10
6秒前
华仔的应助被科研通管家采纳,获得10
6秒前
6秒前
ding的应助被科研通管家采纳,获得10
6秒前
可靠蜻蜓完成签到,获得积分10
6秒前
辣椒发布了新的文献求助10
6秒前
尕辉完成签到,获得积分10
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187918
求助须知:如何正确求助?哪些是违规求助? 9575850
关于积分的说明 21843829
捐赠科研通 7785760
什么是DOI,文献DOI怎么找? 3435128
关于科研通互助平台的介绍 2559501
邀请新用户注册赠送积分活动 2482027